z-logo
open-access-imgOpen Access
Pharmacokinetics of four different brands of colistimethate and formed colistin in rats
Author(s) -
Huiling He,
J.-C. Li,
Roger L. Nation,
Jovan Jacob,
Gong Chen,
H. J. Lee,
Brian T. Tsuji,
Philip E. Thompson,
Kevin Roberts,
Tony Velkov,
Jian Li
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt207
Subject(s) - colistin , pharmacokinetics , prodrug , pharmacology , antibiotics , chemistry , medicine , biochemistry
Very different labelling conventions are employed by different products of colistimethate (CMS), an inactive prodrug of colistin that is used as a last-line defence against Gram-negative 'superbugs'. This study examined the chemical composition and pharmacokinetics in rats of four commercial parenteral products of CMS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom